Drawing for PREVASCAR

USPTO serial 78565994

PREVASCAR

Reviewed by CopyMark Law Group

Reg. 3339269Status 710
Filing date
Status date
Registration date
Nov 20, 2007
Examiner
SAKAI, ADA HAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PREVASCAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

WILLIAM C WRIGHT EPSTEIN DRANGEL BAZERMAN & JAMES LLP60 E 42ND ST RM 820NEW YORK, NY 10165-0820UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely; wound healing preparations, preparations for the prevention, reduction, inhibition or treatment of scarring; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of fibrosis; Pharmaceutical preparations for the treatment, inhibition or prevention of the development of fibrotic conditions; Pharmaceutical preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in connection with elective surgery and trauma treatment of nerves, and with surgery of nerves or trauma; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of dermal wounds; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of dermal scarring; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of dermal fibrotic conditions; Pharmaceutical preparations for the treatment of damaged ligaments, tendons or cartilage; Pharmaceutical preparations for the promotion of re-epithelialization; Pharmaceutical preparations for the treatment of chronic wounds; Pharmaceutical preparations for the treatment of burns; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of ulcers or pressure sores; Pharmaceutical preparations for the treatment, reduction, inhibition or prevention of adhesions and strictures; Pharmaceutical preparations for the treatment of cardiovascular and vascular restenosis; Pharmaceutical preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in the treatment of the eye; Pharmaceutical preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in the treatment of nerves, and used during surgery of nerves or traumaSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2014C8..CANCELLED SEC. 8 (6-YR)—
Nov 20, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 4, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 15, 2007NPUBNOTICE OF PUBLICATION—
Aug 1, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 31, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 31, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jul 31, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 31, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 31, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 31, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 31, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 31, 2007LIECLEGAL INSTRUMENT EXAMINER (LIE) - CORRECTION—
Jul 25, 2007LIECLEGAL INSTRUMENT EXAMINER (LIE) - CORRECTION—
Jul 13, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 9, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 9, 2007ALIEASSIGNED TO LIE—
Oct 27, 2006RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 26, 2006ATRVATTORNEY REVIEW COMPLETED—
Oct 25, 2006RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 19, 2006ATRVATTORNEY REVIEW COMPLETED—
Sep 8, 2006UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Aug 29, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Apr 10, 2006CNSLSUSPENSION LETTER WRITTEN—
Mar 30, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2005DOCKASSIGNED TO EXAMINER—
Feb 24, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance